The neural crest (NC) is a multipotent embryonic cell population generating distinct cell types 30 in an axial position-dependent manner. The production of NC cells from human pluripotent 31 stem cells (hPSCs) is a valuable approach to study human NC biology. However, the origin 32 
Introduction 42
The neural crest (NC) is a multipotent cell population which arises in the dorsal neural 43 plate/non-neural ectoderm border region during vertebrate embryogenesis. Studies utilising 44 chick and amphibian embryos have indicated that different levels of BMP, WNT and FGF 45 signals, emanating from the mesoderm/non-neural ectoderm, orchestrate NC induction and 46 specification (1). This occurs via the action, first of neural plate border-specific transcription 47 factors such as PAX3/7, MSX and ZIC family members, and then via definitive NC-specifiers 48 (e.g. SOX9/10) (2). Once specified, NC cells undergo epithelial-to-mesenchymal transition 49 (EMT), exit the neural tube, and migrate to generate various cell types. The identity of NC 50 products correlates to their position along the anteroposterior (A-P) axis, which is in turn 51 reflected by the expression of paralogous HOX gene groups. Cranial NC cells give rise to 52 mesoectodermal derivatives (e.g. dermis, cartilage, bone), melanocytes, neurons and glia 53 colonizing the head (3) and are divided into an anterior HOX-negative and a posterior HOX 54 group(1-3)-positive domain. The latter also includes cells contributing to heart structures 55 (termed cardiac NC) (3, 4). Vagal NC cells, which are located between somites 1-7, arealso show that "caudalisation" via RA treatment of anterior NC precursors leads to the 113 acquisition of a mixed cardiac and vagal NC identity rather than a trunk NC character and 114 define novel markers of distinct posterior NC subtypes. Finally, we utilise our findings to 115 establish a protocol for the in vitro generation of PHOX2B+ sympathoadrenal cells and 116 sympathetic neurons at high efficiency from cultures of posterior axial progenitor-derived 117 trunk NC cells without the need for FACS-sorting to select for minor precursor 118 subpopulations. Taken together these findings provide an insight into the mechanisms 119 underpinning the "birth" of human NC cells at different axial levels and pave the way for the 120 modelling of trunk NC-linked diseases such as neuroblastoma. 121
122

Results
123
Transcriptome analysis of human axial progenitors 124
We and others have previously shown that combined stimulation of the WNT and FGF 125 signalling pathways in PSCs leads to the production of a high (>80%) percentage of 126 T+SOX2+ cells. The resulting cultures resemble embryonic posterior axial progenitors, 127 including NMPs, both in terms of marker expression and developmental potential (38, (42) (43) (44) 128 49). To interrogate the transcriptome changes associated with the induction of such 129 progenitors in a human system and identify the presence of trunk NC precursors, we carried 130 out RNA sequencing (RNAseq) following 3-day treatment of hPSCs with recombinant FGF2 131 and the WNT agonist/GSK-3 inhibitor CHIR99021 (CHIR). As reported previously, most cells 132 emerging under these conditions co-expressed T and SOX2 as well as CDX2 ( Figure 1A) . 133 We found that the transcriptomes of hNMPs and hPSCs were markedly distinct from each 134 other (Figures S1A, S1B) and dramatic global gene expression changes accompanied the 135 acquisition of an axial progenitor character: 1911 and 1895 genes were significantly 136 (padj<0.05; Fold Change >= 2) up-and down-regulated compared to hPSCs respectively 137 (Table S1) . Predictably, the top-downregulated genes were associated with undifferentiated 138 hPSCs (e.g. NANOG, GDF3, POU5F1), anterior neurectoderm (OTX2) and lateral/ventral 139 mesoderm (KDR). The vast majority of the top-upregulated genes were well-establisheddrivers of axis elongation (e.g. TBRA, CDX1/2, EVX1, MSGN1, TBX6) and 141 WNT/FGF/NOTCH/RA signalling pathway components, known to be expressed at high 142 levels in the late PS/TB regions in vivo (e.g. WNT3A/5B, RSPO3, FGF4/8, FGF17, HES7) 143 (Figures 1B, S1C , S1D, Table S1 ). A large fraction of upregulated genes were 144 transcriptional regulators ( Figure S1D , Table S1 ) and we found that members of HOX gene 145 clusters belonging to paralogous groups 1-9 were strongly differentially expressed between 146 the two groups ( Figure 1C , S1E, Table S1 ). The upregulation of posterior thoracic (group 5-147 9) HOX transcripts as well as the presence of many transcripts (23/32) marking "late" E9.5 148 mouse embryonic NMPs such as CYP26A1, FGF17 and WNT5A (38) We next sought evidence pointing to the potential links between trunk NC and human axial 156
progenitors. The RNAseq analysis revealed that a considerable number of genes known to 157 collectively mark the neural plate border and early NC in vivo ("NC/border" e.g. SOX9, 158 PAX3, MSX1/2, SNAI1/2, ZIC1/3) were also significantly upregulated in axial progenitors 159 (Figure 2A) , a finding which was further verified using quantitative real time PCR (qPCR) 160 ( Figure S2A) . To exclude the possibility that the presence of such markers was the result of 161 spontaneous differentiation of NM bipotent axial progenitors and their neural derivatives we 162 examined their co-expression with T, a marker of both NMPs and prospective PXM. 163
Immunostaining of d3 WNT-FGF-treated hPSC cultures showed that a considerable fraction 164 of T+ cells also expressed the early NC markers/specifiers SOX9, SNAI2 and PAX3 (Figure  165 2B). Moreover, SOX9-positive cells were found to express low or no MSGN1 or TBX6 166 ( Figure S2B ) suggesting that the upregulation of border/NC markers following WNT-FGF 167 treatment of hPSCs was unlikely to reflect the presence of committed PXM cells given thatsome of these genes are also expressed in the mesoderm during axis elongation. 169
Collectively, these findings indicate that a NC/border state probably arises within multipotent 170 posterior axial progenitors which have not committed to a neural or mesodermal fate. 171
A number of both in vivo and in vitro studies have pointed to an optimal level of 172 low/intermediate BMP signalling acting as an inducer of a NC/border character in 173 conjunction with WNT and FGF (14, 16, 48, [50] [51] [52] [53] . We therefore examined whether hPSC-174 derived axial progenitor cultures exhibit endogenous BMP activity. RNAseq revealed that 175 many BMP pathway -associated transcripts (BMP2/4/6/7 and ID1/4) were significantly 176 upregulated compared to hPSCs (Figure 2A) . Moreover, antibody staining showed 177 expression of phosphorylated SMAD1/5, a readout of BMP activity ( Figure 2C ). This is 178 extinguished upon treatment with the BMP antagonist LDN193189 (LDN) (54) during the in 179 vitro differentiation of hPSCs to day 3 axial progenitors ( Figure 2C) . Interestingly, BMP 180 inhibition also caused a decrease in the transcript levels of most border/NC-specific 181 transcripts with PAX3 and MSX1 being the most severely affected ( Figure 2D ). We also 182 observed a reduction in the NMP/late PS/TB markers CDX2 and WNT3A whereas the PXM 183 specifier TBX6 remained relatively unaffected by LDN treatment suggesting that emergence 184 of prospective PXM is not influenced by BMP inhibition ( Figure 2D ). By contrast, SOX2 185 expression was markedly increased upon LDN treatment ( Figure 2D) . Taken together these 186 data indicate a correlation between endogenous BMP activity and the acquisition of a 187 SOX2+low border/NC identity by posterior axial progenitors while transition toward a SOX2+ 188 high neural fate relies on BMP antagonism in vitro. previous reports which show that NC specification takes place prior to definitive neurulation 206 (48, 55, 56) . Furthermore, during the transition toward trunk neural crest, the NMP/pre-207 neural marker NKX1-2 was rapidly extinguished followed shortly after by T, while CDX1 208 transcript levels declined more slowly (Figure S3A, S3B) . By contrast, the expression of 209 CDX2 and SOX9 was maintained at high levels (>70% of total cells) throughout the course 210 of differentiation of axial progenitors to trunk NC while SOX10 expression appeared only 211 after day 7 of differentiation (Day 0 defined as the start of axial progenitor induction from 212 hPSCs) ( Figure S3C , data not shown). We also confirmed the NM potency of the starting 213 axial progenitor cultures as treatment with high levels of FGF2/CHIR and RA led to the 214 production of TBX6+ PXM and SOX1+ spinal cord, posterior neurectoderm (PNE) cells 215 respectively ( Figure 3A, 3D) . Taken together these data suggest that hPSC-derived NM-216 potent axial progenitor cultures are competent to produce trunk NC at high efficiency. 217
Similar to popular in vitro neural induction strategies, most current NC differentiation 218 protocols aiming to generate posterior (e.g. trunk) cell populations from hPSCs rely on the 219 caudalisation of an anterior ectodermal precursor via treatment with RA and/or WNT 220 agonists (15, (17) (18) (19) (20) . Therefore, we compared our axial progenitor-based approach for 221 generating trunk NC to a conventional strategy involving the generation of anterior cranial 222 NC (ANC) precursor cells (16) followed by RA addition in the presence of WNT and BMP 223 signalling ( Figure 4A) . The axial identity of the resulting cells was assessed by qPCR assayof HOX transcripts corresponding to different levels along the A-P axis. In line with previous 225 findings (17, 19) RA-treated cells expressed high levels of HOX group 1-5 members 226 compared to untreated NC suggesting a posterior cranial and vagal/cardiac NC character 227 ( Figure 3E) . However, efficient induction trunk of HOXC8 and 9 transcripts was only 228 achieved when posterior axial progenitors were employed as the starting population for NC 229 generation ( Figure 3E) . Furthermore, axial progenitor-derived NC cells were marked by 230 increased expression of the trunk NC marker HES6, but did not express the cranial markers 231 OTX2, DMBX1 and LHX5 although they were positive for the "late" cranial NC transcripts 232 (TFA2B, ETS1, SOX8) (57) ( Figure 3F ). We thus conclude that posterior axial progenitors 233 Table S2 ). We also identified ASLX3, the human homologue of the Drosophila polycomb 262 protein asx (68) which has been recently linked to the developmental syndrome Ropers (69) has been shown to be expressed in mouse NC derivatives (70) and TCF7L2, a WNT 266 signalling effector which has been reported to harbour a NC-associated enhancer (71) 267 (Tables S2, S3 ). Collectively these data support the idea that a mixed posterior 268 cranial/vagal/cardiac NC character arises upon treatment of anterior NC precursors with RA 269 whereas a bona fide trunk NC identity can be achieved only via an axial progenitor 270
intermediate. 271
One of the most over-represented gene categories in all three axial NC subtypes 272
were transcription factors and a common NC-specific transcription factor module was found 273 to be expressed regardless of axial character ( Figure S4B , Table S3, Table S4 ). This 274 included well-established border/NC regulators such as PAX3/7, MSX2, SOX9/10, TFAP2A-275 C and SNAI1/2 ( Figure S4C , Tables S3, S4 ). However, the expression levels of many of 276 these transcription factors varied between the three groups ( Figure S4C ). The highest levels 277 of HES6, FOXD3 and MSX1/2 were found in axial progenitor-derived trunk NC cells whereas 278 high PAX7 and SNAI1/ SOX9 expression was more prevalent in the anterior cranial and RA-279 treated samples respectively ( Figure S4C) . Comparison of the day 6 trunk and d3 ANCprecursor transcriptomes also revealed that expression of LHX5 and DMBX1 marks an 281 anterior NC state whereas HES6 is associated exclusively with a trunk fate ( Figure S4D ) 282 indicating that diversification of axial identity in NC cells starts at an early time point via the 283 action of distinct molecular players. 284
285
Distinct routes to posterior neural crest fates 286
To identify candidate genes mediating the gradual lineage restriction of trunk NC precursors 287 present in axial progenitor cultures we compared the transcriptomes of d6 trunk NC 288 precursors and day 3 WNT-FGF-treated hPSCs (="NMPs"). We found that dramatic global 289 gene expression changes take place during the axial progenitor-trunk NC transition ( Figure  290 4G, S4E). Some of the most upregulated transcripts were the NC-specific TFAP2A/B, ETS1, 291 SOX5 and SOX10 together with the established trunk NC specifier CDX2, the novel trunk 292 NC marker ASLX3, the nuclear receptors NR2F1/2 and thoracic HOX genes (HOXB7, B9) 293 Table S4 ). In contrast, signature axial progenitor transcription factors such as 294 T, MIXL1, NKX1-2, anterior HOX genes (HOXA1/B1) and some WNT signalling components 295 (WNT8A/5B) were significantly downregulated ( Figure 4G , Table S4 ). Thus differentiation of 296
trunk NC precursors appears to involve the transition from an axial progenitor-associated 297 gene regulatory network to a NC-specifying one that incorporates factors which potentially 298 act as general determinants of posterior cell fate (CDX2, HOXB9). 299
We also examined transcriptome changes during the transition from an anterior NC 300 precursor state (ANC d3) to RA-posteriorised vagal/cardiac NC cells (+RA d6). The most-301 highly induced transcripts in posterior cranial/cardiac/vagal NC cells included the RA 302 receptors beta and gamma (RARb/g) which have been involved in hindbrain and neural crest 303 patterning (72) and the T-box transcription factor TBX2, a marker of cardiac NC and in vitro 304 derived vagal/enteric NC progenitors (19) ( 
Efficient in vitro generation of sympathoadrenal cells from axial progenitors 314
We next sought to determine whether trunk NC cells derived from axial progenitors are the 315 optimal source of sympathoadrenal (SA) progenitors and their derivatives. The BMP and 316 sonic hedgehog (SHH) signalling pathways have been shown to be critical for the 317 specification of these lineages from NC cells (74, 75). Therefore we cultured d8 trunk NC 318 cells generated from axial progenitors carrying a GFP reporter within the SA/sympathetic 319 neuron regulator PHOX2B locus (18, 76) , in the presence of BMP and sonic hedgehog 320 (SHH) signalling agonists ( Figure 5A ). GFP expression was assayed after 4 days of culture 321 of trunk NC cells in BMP4 and SHH agonists (i.e. day 12 of differentiation) ( Figure 5B) . 322 FACS analysis revealed that the majority of cells were PHOX2B expressing (average 323 percentage from four independent experiments=73.5%, s.d.= 6.344) ( Figure 5B) and a 324 large proportion of them were also positive for the early SA progenitor marker ASCL1 (77) 325 indicating that they had acquired a symphathoadrenal identity ( Figure S5A ). Further 326 maturation of the resulting SA progenitors in the presence of neurotrophic factors (BDNF, 327 GDNF and NGF) for a further 6-8 days resulted in the induction of a high yield of 328 sympathetic neurons/progenitors co-expressing PHOX2B together with the sympathetic 329 neuron regulator GATA3 (78) (average of 40% of total cells), ASCL1 (63%) and the SA 330 differentiation regulator ISL1 (64%) (Figure 5C, 5D) . A high proportion of the resulting cells 331 also expressed the dopamine production-associated enzyme/sympathetic neuron marker 332 tyrosine hydroxylase (TH) (79) (Figure 5D) . Furthermore, the cultures widely expressed the 333 peripheral nervous system marker PERIPHERIN (PRPH) (80) together with the trunk axial 334 marker HOXC9 ( Figure S5B) . We also detected dramatic induction of GATA3, ASCL1, TH 335 and PHOX2B transcripts (between 1000 and 1,000,000-fold) as well as other SA lineagemarkers such as GATA2, DBH (dopamine-β-hydroxylase) and to a lesser extent PHOX2A 337 using qPCR ( Figure 5E ). Together, these results suggest that the optimal route toward the 338 (Fig. 6) . This finding offers an explanation for the failure of current RA 366 posteriorisation-based in vitro differentiation protocols (17, 19) to yield high numbers of 367 HOX9+ trunk NC cells and should serve as the conceptual basis for the design of 368 experiments aiming to generate NC cells of a defined A-P character from hPSCs. 369
Our data indicate that a subpopulation of in vitro derived human axial progenitors 370 acquires border/early NC characteristics in response to the WNT and FGF signals present in 371 the differentiation culture media, and under the influence of autocrine BMP signalling. This is 372 in line with bulk and single cell transcriptome data showing that mouse embryonic axial 373 progenitors/NMPs express border and early NC markers (38, 41). Furthermore, our data 374 reflect findings in the chick embryo showing that an "unstable", pre-neural plate border 375 domain, potentially defined by the co-localisation of pre-neural (Nkx1-2) (81) and border 376 markers such as Pax3 (82) and Msx1, arises in the avian embryonic caudal lateral epibllast 377 in response to autocrine BMP, FGF (51) and possibly WNT signalling (83). We also found 378 that CDX2 expression is maintained at high levels during the generation of trunk NC 379 indicating that this transcription factor might be critical in inducing an NC character in axial 380 progenitors. CDX2 has been shown, together with β-catenin, to bind and activate neural 381 plate border/early NC specifiers such as MSX1 and ZIC1 (47, 84) and, intriguingly, ChiP-Seq 382 data from in vitro-derived mouse NMPs have revealed that many border/NC genes are direct 383 targets of CDX2 often jointly with T (e.g. PAX3, SOX9, ZIC3) (39). Collectively these findings 384 raise the possibility that β-catenin and CDX2, in conjunction with FGF/BMP signalling, may 385 be critical for the establishment of a border/NC identity in T+ axial progenitors and further 386 work is required to test this hypothesis. 387
We show that BMP/WNT treatment of human axial progenitors promotes the 388 induction of a definitive trunk NC state. This transition appears to coincide with the 389 progressive extinction of key axial progenitor genes and their replacement by a battery of 390 NC-specific transcription factors such as TFAP2B, SOX10, NR2F2 and NR2F1 while the 391 levels of some "common" axial progenitor-NC markers (e.g. SOX9, PAX3, TFAP2A andSNAI2) remain high (Figure 4, S3, Table S4 ). TFAP2A has been previously reported to act 393 as a master NC transcription factor whose binding on key enhancers, together with 394 NR2F1/2, appears to initiate transcription of NC-specific genes (71). This finding raises the 395 possibility that these transcription factors are the molecular drivers of the transition from an 396 early posterior axial progenitor state to a lineage-restricted trunk NC fate in response to 397 BMP/WNT. How is a trunk axial character specified? Our transcriptome analysis data 398 suggest that a generic trunk identity is first installed during the emergence of multipotent 399 Table S1 . 450 The detailed list of all TFs can be found in Table S3 . ( 
Cell culture and differentiation 566
We employed the following hPSC lines: a Shef4-derived Sox2-GFP reporter hESC line (44), 567 the H9-derived SOX10-GFP (15) and PHOX2B-GFP (18) only day (10 µM, Tocris). We observed some variation in terms of induction of T+SOX2+ 582
NMPs both between hPSC lines and also batches of CHIR99021 and thus the concentration 583 of the latter was varied between 3-4 µM. BMP inhibition was carried out using LDN193189 584 (Tocris) at 100 nM. For trunk NC differentiation day 3 hPSC-derived axial progenitors were 585 dissociated using accutase and re-plated at a density 30,000 cells /cm 2 on Geltrex (Thermo 586 Fisher)-coated plates directly into NC-inducing medium containing DMEM/F12 (Sigma), 1xN2 supplement (Thermo Fisher), 1x Non-essential amino acids (Thermo Fisher) and 1x 588 Glutamax (Thermo Fisher), the TGFb/Nodal inhibitor SB431542 (2 µM, Tocris), CHIR99021 589
(1 µM, Tocris), DMH1 (1 µM, Tocris), BMP4 (15 ng/ml, Thermo Fisher) and Y-27632 (10 590 µM, Tocris). The medium was replaced at days 5 and 7 of differentiation but without the 591 ROCK inhibitor and trunk NC cells were analysed either at day 8 or 9. For cranial neural 592 crest differentiation hPSCs were dissociated using accutase and plated under the same NC-593 inducing conditions as described above for 5-6 days. For posterior cranial/vagal/cardiac NC 594 generation d4 differentiated anterior NC progenitors induced as described above were 595 treated with retinoic acid (1 µM, Tocris) in the presence of the NC-inducing medium till day 6 596 of differentiation. For sympathoadrenal progenitor (SAP) differentiation d8 trunk NC cells 597 were re-suspended at a density of 200-300,000 cells /cm 2 on Geltrex (Thermo Fisher)-598 coated plates directly into medium containing BrainPhys neuronal medium (Stem Cell 599 Technologies), 1x B27 supplement (Thermo Fisher), 1x N2 supplement (Thermo Fisher), 1x 600
Non-essential amino acids (Thermo Fisher) and 1x Glutamax (Thermo Fisher), BMP4 (50 601 ng/ml, Thermo Fisher), recombinant SHH (C25II) (50 ng/ml, R&D) and purmorphamine 602
(1.25-1.5 µM, Millipore) and cultured for 4 days (d12 of differentiation). For further 603 sympathetic neuron differentiation d12 SAP cells were switched into a medium containing 604
BrainPhys neuronal medium (Stem Cell Technologies), 1x B27 supplement (Thermo Fisher), 605 1x N2 supplement (Thermo Fisher), 1x Non-essential amino acids (Thermo Fisher) and 1x 606 Glutamax (Thermo Fisher), ascorbic acid (200 µM, Sigma) , NGF (10 ng/ml, Peprotech), 607 BDNF (10 ng/ml, Peprotech) and GDNF (10 ng/ml, Peprotech) and cultured for a further 6-8 608 days. For paraxial mesoderm differentiation d3 axial progenitor cultures were treated with 609 accutase and replated at a density of 45,000/cm 2 on 12-well Geltrex-coated plates in N2B27 610 containing FGF2 (40 ng/ml, Peprotech) and CHIR99021 (8 µM, Tocris) for two days. For 611 neural differentiation d3 axial progenitor cultures were treated with accutase and replated at 612 a density of 45,000/cm 2 on 12-well Geltrex-coated plates in N2B27 containing 100 nM 613 retinoic acid (Tocris) for 2-3 days. 614
Sample preparation 616
For RNA sequencing we employed hESCs or axial progenitors following culture on 617 fibronectin in FGF2 (20 ng/ml) and CHIR99021 (3 µM). Total RNA from NMPs and hESCs 618 was harvested using the RNeasy kit (Qiagen) according to the manufacturer's instructions. 619
Library preparation/sequencing 620
Total RNA was processed according to the TruSeq protocol (Illumina). Three separate RNA 621 libraries (biological replicates) were barcoded and prepared for hPSCs and D3 axial 622 progenitors. Library size, purity and concentration were determined using the Agilent 623
Technologies 2100 Bioanalyzer. For sequencing, four samples were loaded per lane on an 624
Illumina Genome Analyzer Hiseq2500. 625
RNAseq quality control and mapping 626
The quality of raw reads in fastq format was analyzed by FastQC 627 Single-end clean reads were aligned to the human reference genome (hg38 assembly) using 631 Tophat2 v2.0.13 (87). 632
RNA seq data analysis 633
Read alignments were sorted with SAMtools v1.1 before being counted to genomic features 634 by HTSeq version 0.6.0 (88). The average overall read alignment rate across all samples 635 was 94.3%. Differential gene expression was performed using DESeq2 version 1.16.1 (89). 636 in R version 3.3.3. Genes were considered significantly differentially expressed (DE) with a 637
Benjamini-Hochberg adjusted pvalue <=0.05 and a log2FoldChange> |1|. Gene Ontology 638 (GO) biological processes (BP) enrichment analysis was carried out for DE genes using the 639 DAVID gene ontology functional annotation tool (https://david.ncifcrf.gov/) 640 (90, 91) with default parameters. We considered as significant terms having a FDR adjusted 641 pvalue <= 0.05, which is derived from a modified Fisher's exact test. 642
Microarrays 644
Sample preparation and processing 645
Samples were prepared according to the Affymetrix WT Plus protocol for Gene Chip ® 646
Whole Transcript Expression Arrays. Briefly 200ng of high quality total RNA, (RNA integrity 647 number (RIN) greater than 9), was converted to double stranded cDNA with the introduction 648 of a T7 polymerase binding site. This allowed the synthesis of an antisense RNA molecule 649 against which a sense DNA strand was prepared. The RNA strand was digested and the 650 resulting single stranded DNA fragmented and biotin labelled. Along with appropriate 651 controls the labelled fragmented DNA was hybridised to Affymetrix Clariom D arrays 652 overnight using the Affymetrix 640 hybridisation oven; 16 hours with rotation at 60 rpm at 653 45 0 C. The arrays were washed and stained according to standard protocols which allowed 654 the introduction of streptavidin-phycoerythrin in order to generate a fluorescent signal from 655 the hybridised biotinylated fragments. The washed and stained arrays were scanned using 656 the Affymetrix 3000 7G scanner with autoloader. The generated CEL files were taken 657 forward for analysis. 658
Data analysis 659
Data were analysed using the Affymetrix Transcriptome Analysis Console 4.0 software. 660 Analysis of Expression (Gene+Exon) was used to generate lists of all differentially 661 expressed genes showing >2; <-2 fold Log Change and P<0.05. For the distance matrix 662 (Figure S4A ), Exploratory Grouping analysis was used. Log 2 normalised intensity data 663 values were mapped in R using the package 'pheatmap' with correlation clustering by gene. 664
Gene ontology analysis was carried out using the ToppGene suite 665 (https://toppgene.cchmc.org/enrichment.jsp) (92). Area proportional 3-Venn diagrams were 666 drawn using the eulerApe software (93). 667
Quantitative real time PCR 668
Total RNA from different samples was harvested using the RNeasy kit (Qiagen) according to 669 the manufacturer's instructions and digested with DNase I (Qiagen) to remove genomic 670 Fisher) using random primers. Quantitative real time PCR was carried out using the Applied 672
Biosystems QuantStudio™ 12K Flex thermocycler together with the Roche UPL system. 673
Primer sequences are shown in Table S5 . 674
Flow cytometry 675
Cells were lifted into a single cell suspension using Accutase (as previously described) and 676 resuspended in FACS buffer (DMEM with 10% v/v FCS) to neutralise Accutase before 677 centrifugation at 1100rpm/4min. Cells were then resuspended in FACs buffer at 1x106 678 cells/ml and 100,000 cells were placed in FACs tubes (Falcon 352053). A GFP baseline was 679 set using unmodified wild type control cells. 680
Immunofluorescence 681
Cells were fixed for 10 minutes at 4°C in 4% paraformaldehyde (PFA) in phosphate buffer 682 saline (PBS), then washed in PBST (PBS with 0.1% Triton X-100) and treated with 0.5 M 683 glycine/PBST to quench the PFA. Blocking was then carried for 1-3 h in PBST supplemented 684 with 3% donkey serum/1% BSA at room temperature or overnight at 4 0 C. Primary and 685 secondary antibodies were diluted in PBST containing in PBST supplemented with 3% 686 donkey serum/1% BSA. Cells were incubated with primary antibodies overnight at 4°C and 687 with secondary antibodies at room temperature for 2 h in the dark. Cell nuclei were 688 counterstained using Hoechst 33342 (1:1000, Thermo Fisher) and fluorescent images were 689 taken using the InCell Analyser 2500 system (GE Healthcare). We used the following 690 antibodies: anti-T (1∶200; AF2085, R&D), anti-SOX2 (1:200; ab92494, Abcam), anti-SOX9 691 Santa Cruz), anti-GFP (1:1000; ab13970, Abcam), anti-ISL1 (1:100, DSHB), anti-PHOX2B 697
(1:100; sc-376997, Santa Cruz). Images were processed using Photoshop and Fiji. Nuclear 698 segmentation followed by single cell fluorescence quantification was performed as described 699 previously using Fiji and the MultiCell3D application as described previously (35, 94) . 700
Data availability 701
The microarray and RNAseq data have been deposited to GEO (GSE109267 and 702 
GSE110608
